Not Signed In -
Opsoclonus Myoclonus |
|
|
Opsoclonus myoclonus syndrome (OMS) is a rare neurological disorder of unknown causes which appears to be the result of an autoimmune process involving the nervous system. It is an extremely rare condition, affecting as few as 1 in 10,000,000 people per year. It affects 2 to 3 % of children with neuroblastoma. Nomenclature OMS was first described by Dr. M. Kinsbourne in 1962 (The term 'Opsoclonus' was coined by Orezechowski in 1913, but it was classically described and associated with ne ...
Wikipedia - [full article]
Opsoclonus Myoclonus Clinical Trials
- Effectiveness of Rituximab in Pediatric OMS Patients.
ClinicalTrials.gov Identifier: NCT00244361 - Active, not recruiting
Opsoclonus-Myoclonus Syndrome; Opsoclonus; Myoclonus; Ataxia
- Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
ClinicalTrials.gov Identifier: NCT00202930 - Recruiting
Neuroblastoma; Opsoclonus-Myoclonus
- Pilot Efficacy Study of T2000 in Myoclonus Dystonia
ClinicalTrials.gov Identifier: NCT00506012 - Recruiting
Myoclonus
- Treatment of Cortical Myoclonus with Repetitive Transcranial Magnetic Stimulation
ClinicalTrials.gov Identifier: NCT00001663 - Completed
Movement Disorder; Myoclonus; Nervous System Disease
- Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases
ClinicalTrials.gov Identifier: NCT00001667 - Completed
Movement Disorders; Myoclonus; Nervous System Diseases; Tic Disorders; Tremor
Resources
- Dancing Eyes-Dancing Feet Syndrome (National Institute of Neurological Disorders and Stroke)
- Opsoclonus myoclonus (Cleveland Clinic)
email this page
print this page
bookmark this page
feedback on this page
